Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 25.30
+1.16 (4.81%)
At close: Sep 30, 2026
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 9.28 billion as of October 2, 2026. Its market cap has decreased by -18.12% in one year.
Market Cap
9.28B
Enterprise Value
8.55B
Revenue
338.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.30
ChartMarket Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 9.28B, a decrease of -25.63%. That is a compound annual growth rate of -8.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 9.28B | -7.12% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 10.55B |
| Chengzhi | 10.50B |
| Staidson (Beijing) BioPharmaceuticals | 9.77B |
| Jiangxi Fushine Pharmaceutical | 9.62B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.41B |
| Pacific Shuanglin Bio-pharmacy | 9.14B |
| Chengdu Easton Biopharmaceuticals | 8.88B |
| Vcanbio Cell & Gene Engineering Corp., | 8.85B |